Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPension (IS)Preferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bruker (BRKR) EBITDA (2016 - 2025)

Bruker (BRKR) has disclosed EBITDA for 16 consecutive years, with $12.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA fell 82.39% year-over-year to $12.7 million, compared with a TTM value of $4.6 million through Dec 2025, down 98.18%, and an annual FY2025 reading of $4.6 million, down 98.18% over the prior year.
  • EBITDA was $12.7 million for Q4 2025 at Bruker, up from -$51.8 million in the prior quarter.
  • Across five years, EBITDA topped out at $131.0 million in Q4 2022 and bottomed at -$51.8 million in Q3 2025.
  • Average EBITDA over 5 years is $54.0 million, with a median of $56.1 million recorded in 2023.
  • The sharpest move saw EBITDA skyrocketed 240.88% in 2023, then crashed 176.06% in 2025.
  • Year by year, EBITDA stood at $80.6 million in 2021, then soared by 62.53% to $131.0 million in 2022, then dropped by 20.99% to $103.5 million in 2023, then tumbled by 30.34% to $72.1 million in 2024, then tumbled by 82.39% to $12.7 million in 2025.
  • Business Quant data shows EBITDA for BRKR at $12.7 million in Q4 2025, -$51.8 million in Q3 2025, and $11.9 million in Q2 2025.